4-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl]-N-(4-methylpyridin-2-yl)-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide
Chemical Structure Depiction of
4-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl]-N-(4-methylpyridin-2-yl)-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide
4-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl]-N-(4-methylpyridin-2-yl)-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide
Compound characteristics
| Compound ID: | L309-1281 |
| Compound Name: | 4-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl]-N-(4-methylpyridin-2-yl)-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide |
| Molecular Weight: | 455.49 |
| Molecular Formula: | C21 H21 N5 O5 S |
| Smiles: | Cc1ccnc(c1)NS(c1ccc2c(c1)N(Cc1nc(C3CCC3)on1)C(CO2)=O)(=O)=O |
| Stereo: | ACHIRAL |
| logP: | 2.2132 |
| logD: | 2.0977 |
| logSw: | -2.8812 |
| Hydrogen bond acceptors count: | 11 |
| Hydrogen bond donors count: | 1 |
| Polar surface area: | 107.524 |
| InChI Key: | NINIDLWXQURQLQ-UHFFFAOYSA-N |